Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Mechanisms of increased mitochondria-dependent necrosis in Wiskott-Aldrich syndrome platelets.

Obydennyi SI, Artemenko EO, Sveshnikova AN, Ignatova AA, Varlamova TV, Gambaryan S, Lomakina GY, Ugarova NN, Kireev II, Ataullakhanov FI, Novichkova GA, Maschan AA, Shcherbina A, Panteleev M.

Haematologica. 2019 Jul 5. pii: haematol.2018.214460. doi: 10.3324/haematol.2018.214460. [Epub ahead of print]

2.

[PULMONARY AUTOGRAFT OPERATION IN PEDIATRIC PATIENTS].

Romanyuk OM, Klymyshyn YI, Artemenko EO, Rudenko NM, Yemets IM.

Klin Khir. 2017;(2):19-21. Ukrainian.

PMID:
30272904
3.

Calpain-controlled detachment of major glycoproteins from the cytoskeleton regulates adhesive properties of activated phosphatidylserine-positive platelets.

Artemenko EO, Yakimenko AO, Pichugin AV, Ataullakhanov FI, Panteleev MA.

Biochem J. 2016 Feb 15;473(4):435-48. doi: 10.1042/BJ20150779. Epub 2015 Nov 25.

PMID:
26607836
4.

Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.

Zakharova NV, Artemenko EO, Podoplelova NA, Sveshnikova AN, Demina IA, Ataullakhanov FI, Panteleev MA.

PLoS One. 2015 Feb 17;10(2):e0116665. doi: 10.1371/journal.pone.0116665. eCollection 2015.

5.

Antiplatelet agents can promote two-peaked thrombin generation in platelet rich plasma: mechanism and possible applications.

Tarandovskiy ID, Artemenko EO, Panteleev MA, Sinauridze EI, Ataullakhanov FI.

PLoS One. 2013;8(2):e55688. doi: 10.1371/journal.pone.0055688. Epub 2013 Feb 6.

6.

Two types of procoagulant platelets are formed upon physiological activation and are controlled by integrin α(IIb)β(3).

Topalov NN, Yakimenko AO, Canault M, Artemenko EO, Zakharova NV, Abaeva AA, Loosveld M, Ataullakhanov FI, Nurden AT, Alessi MC, Panteleev MA.

Arterioscler Thromb Vasc Biol. 2012 Oct;32(10):2475-83. doi: 10.1161/ATVBAHA.112.253765. Epub 2012 Jul 26.

PMID:
22837472
7.

Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase EphA1.

Bocharov EV, Mayzel ML, Volynsky PE, Goncharuk MV, Ermolyuk YS, Schulga AA, Artemenko EO, Efremov RG, Arseniev AS.

J Biol Chem. 2008 Oct 24;283(43):29385-95. doi: 10.1074/jbc.M803089200. Epub 2008 Aug 26.

8.

Transmembrane domain of EphA1 receptor forms dimers in membrane-like environment.

Artemenko EO, Egorova NS, Arseniev AS, Feofanov AV.

Biochim Biophys Acta. 2008 Oct;1778(10):2361-7. doi: 10.1016/j.bbamem.2008.06.003. Epub 2008 Jun 11.

Supplemental Content

Loading ...
Support Center